COVID-19 TherapeuticsR. Simoneaux, S. Shafer2021ASA Monitor14 citations Open accessSemantic ScholarSave
Monkeypox Outbreak 2022R. Simoneaux, S. Shafer2022ASA Monitor13 citations Open accessSemantic ScholarSave
Update on COVID-19 Vaccine DevelopmentR. Simoneaux, S. Shafer2020ASA Monitor12 citationsSemantic ScholarSave
Are We Facing an Anesthesiologist Shortage?R. Simoneaux2022ASA Monitor5 citationsSemantic ScholarSave
Who Is Immunocompromised?R. Simoneaux, S. Shafer2022ASA Monitor4 citations Open accessSemantic ScholarSave
Can Herd Immunity Save Us from COVID-19?R. Simoneaux, S. Shafer2020ASA Monitor4 citations Open accessSemantic ScholarSave
A Look at the Increasing Incidence of Neuroendocrine TumorsR. Simoneaux20203 citations Open accessSemantic ScholarSave
A Review of Variants & Treatments in Burkitt's LymphomaR. Simoneaux2023Oncology Times2 citationsSemantic ScholarSave
KTE-X19 CAR T Cells in Relapsed/Refractory Mantle Cell LymphomaR. Simoneaux20202 citations Open accessSemantic ScholarSave
A RAS and Bradykinin-Mediated Mechanism for COVID-19R. Simoneaux, S. Shafer20202 citationsSemantic ScholarSave
The Phase I/Ib Trial of WNT Pathway Porcupine Inhibitor CGX1321R. Simoneaux2023Oncology Times1 citations Open accessSemantic ScholarSave
Long COVID RevisitedR. Simoneaux, S. Shafer2022ASA Monitor1 citations Open accessSemantic ScholarSave
Omicron TherapeuticsS. Shafer, R. Simoneaux2022ASA Monitor1 citations Open accessSemantic ScholarSave
How Virulent Is Omicron?R. Simoneaux, S. Shafer2022ASA Monitor1 citations Open accessSemantic ScholarSave
Immune Checkpoint Inhibitor Therapies in Cancer TreatmentR. Simoneaux, S. Shafer2022ASA Monitor1 citations Open accessSemantic ScholarSave
COVID-19 Vaccines Saved LivesR. Simoneaux, S. Shafer2022ASA Monitor1 citations Open accessSemantic ScholarSave
Positive Results for Bispecific DART Flotetuzumab in Patients With AMLR. Simoneaux20211 citations Open accessSemantic ScholarSave
Advances in Pediatric Acute Lymphoblastic Leukemia TreatmentR. Simoneaux2020Oncology Times1 citations Open accessSemantic ScholarSave
Melflufen Approved in EU, Withdrawn in U.S. for Multiple MyelomaR. Simoneaux2025Oncology Times0 citationsSemantic ScholarSave
Predicting Patient Response Using Single-Cell TranscriptomicsR. Simoneaux2024Oncology Times0 citationsSemantic ScholarSave
CLL Treated With Covalent or Non-Covalent BTK InhibitorsR. Simoneaux2024Oncology Times0 citations Open accessSemantic ScholarSave
SIMPLIFY-1 Trial Highlights Transfusion Intensity DataR. Simoneaux2024Oncology Times0 citations Open accessSemantic ScholarSave
FIT Screening for Colorectal Cancer Death PreventionR. Simoneaux2024Oncology Times0 citationsSemantic ScholarSave
Venetoclax + Pi3kδ Inhibitor Roginolisib in Hematologic MalignanciesR. Simoneaux2024Oncology Times0 citations Open accessSemantic ScholarSave
Adjuvant Pembrolizumab in Patients With Clear Cell Renal Cell CarcinomaR. Simoneaux2024Oncology Times0 citationsSemantic ScholarSave
Ruxolitinib for Myelofibrosis Patients Throughout Stem Cell TransplantationR. Simoneaux2024Oncology Times0 citations Open accessSemantic ScholarSave
A Closer Look at the Management of Richter's TransformationR. Simoneaux2023Oncology Times0 citations Open accessSemantic ScholarSave
Glofitamab for Relapsed/Refractory Diffuse Large B-Cell LymphomaR. Simoneaux2023Oncology Times0 citations Open accessSemantic ScholarSave
Trimodality Therapy for Esophageal & GEJ AdenocarcinomaR. Simoneaux2023Oncology Times0 citationsSemantic ScholarSave
Developments of Multiple Myeloma Treatment During the COVID-19 EraR. Simoneaux2023Oncology Times0 citations Open accessSemantic ScholarSave
Research Findings of GD2 CAR T-Cell Therapy for Diffuse Midline GliomasR. Simoneaux2023Oncology Times0 citations Open accessSemantic ScholarSave
A Retrospective Study on Survivors of Diffuse Large B-Cell LymphomaR. Simoneaux2023Oncology Times0 citations Open accessSemantic ScholarSave
Adding Sorafenib to CLAG-M Regimen for AML PatientsR. Simoneaux2023Oncology Times0 citations Open accessSemantic ScholarSave
Respiratory Syncytial Virus and Immunity DebtR. Simoneaux, S. Shafer2023ASA Monitor0 citations Open accessSemantic ScholarSave
Circulating Tumor DNA Analyses for Untreated Metastatic Uveal MelanomaR. Simoneaux2023Oncology Times0 citations Open accessSemantic ScholarSave
Vorasidenib in Residual or Recurrent Grade 2 IDH1/2-Mutated GliomaR. Simoneaux2023Oncology Times0 citations Open accessSemantic ScholarSave
Oncodrivers for Immunotherapies in Triple-Negative Breast CancerR. Simoneaux2023Oncology Times0 citations Open accessSemantic ScholarSave
Biologics 101 for AnesthesiologistsM. Abdalgani, R. Simoneaux, K. Belani2023ASA Monitor0 citations Open accessSemantic ScholarSave
CPX-351 + Gemtuzumab Ozogamicin for Relapsed/Refractory AMLR. Simoneaux2023Oncology Times0 citations Open accessSemantic ScholarSave
Recent Developments in Treating Diffuse Large B-Cell LymphomaR. Simoneaux2023Oncology Times0 citations Open accessSemantic ScholarSave
CAR-T Therapy in Patients With High-Risk Large B-Cell LymphomaR. Simoneaux2023Oncology Times0 citations Open accessSemantic ScholarSave
Promise for Small Molecule FGFR Inhibitor Erdafitinib in Mantle Cell LymphomaR. Simoneaux2023Oncology Times0 citations Open accessSemantic ScholarSave
Registry Highlights AML Trends During COVID PandemicR. Simoneaux2023Oncology Times0 citations Open accessSemantic ScholarSave
